Filing Details

Accession Number:
0001415889-21-001353
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-05 17:55:20
Reporting Period:
2021-03-05
Accepted Time:
2021-03-05 17:55:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
861838 Idera Pharmaceuticals Inc. IDRA Biological Products, (No Disgnostic Substances) (2836) 043072298
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1318485 B Daniel Soland 505 Eagleview Boulevard
Suite 212
Exton PA 19341
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-05 10,000 $3.90 28,843 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct